Posted Notice of Convocation of the 195th Annual Shareholders’ Meeting
Toray Receives Japanese Approval for Additional Indication of Pruritus Treatment REMITCH CAPSULES 2.5 µg and Promotion to Start
Sunovion Pharmaceuticals Inc. Announces Positive Results for Latuda (lurasidone HCl) in First Placebo-Controlled Trial of Patients with Major Depressive Disorder with Mixed (Subsyndromal Hypomanic) Features
Posted Video for Financial Results for FY2014 [Webcast]
Boston Biomedical to Highlight Data Examining Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types at ASCO 2015
"Corporate profile" An English version and a Japanese version are updated.
A Message from the President
Board of Directors and Executive Officers